Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-008109)

Filing Details

Accession Number:: 0000899243-20-008109
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-12 18:34:35
Reporting Period:: 2020-03-10

Accepted Time:: 2020-03-12 18:34:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1771917	Karuna Therapeutics Inc.	KRTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1606826	Heather Preston	C/O Karuna Therapeutics, Inc. 33 Arch Street, Suite 3110 Boston MA 02110		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-10	1,000	$80.00	3,400	No	4	P	Direct
Common Stock	Acquisiton	2020-03-12	550	$69.17	3,950	No	4	P	Direct
Common Stock	Acquisiton	2020-03-12	500	$70.00	4,450	No	4	P	Direct
Common Stock	Acquisiton	2020-03-12	500	$73.00	4,950	No	4	P	Direct
Common Stock	Acquisiton	2020-03-12	500	$74.91	5,450	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $68.69 to $69.4791, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.